Development of an innovative medication support solution

Co-funded by: -Co-funded by

DOSEA project aims to develop a smart label to support drug therapy. This solution is a highly attractive product at pharmaceutical and hospital level, not only for clinical trials but also for home users. This project aims to develop a discreet and intuitive monitoring device which can be easily integrated into different types of medication packaging, including low-cost blister packs or medicine bottles of liquids/powders.

During DOSEA project, the consortium aims to create three products with a high degree of innovation, which allows the patient to monitor the adherence to medication, thus contributing to the mitigation of a global problem and leveraging the regional and national economy.

DOSEA is being developed in partnership with a European project “Sensing Robotics for Smarter Biotechnology – SR4SB”. This project was submitted to the EURIPIDES2 Program, which received approval with the EURIPIDES label.

Main goals

  1. Increase the efficacy of drug therapies;
  2. Promote adequate and timely taking of prescribed medicine;
  3. Preservation and monitoring of medicines under appropriate temperature and humidity conditions;
  4. Develop a sensorization system for validation of medicine intake and innovative monitoring for the pharmaceutical area;
  5. Hardware and firmware improvements, including wireless communication, energy efficiency in the sensorization system and development of an intuitive mobile app.
-The main goals of the project are:

Project Number: POCI-01-0247-FEDER-033664

Approval date: 09 May 2018

Project duration: July 2018 to November 2021

Total eligible cost: 708 606.45 €

Financial support EU: ERDF – 494 008.63 €

Project type: SI I&DT Empresarial – Copromoção

Main objective: Strengthen research, technological development and innovation

Intervention region: Centre and North of Portugal


  • DOSEA basic version is under final prototyping phase.
  • DOSEA + version is under development and further optimizations. To control and monitor this solution an APP is being developed.
  • DOSEA omni version is currently undergoing preliminary studies.


To use our services you must accept our Privacy note.
Privacy Note |